Concurrent versus sequential or no triazole anti-fungal therapy in patients undergoing 7 + 3 plus midostaurin induction for FLT-3 acute myelogenous leukemia.
Dat NgoJose TinajeroJianying ZhangAnthony SteinGuido MarcucciAmandeep SalhotraVinod PullarkatKaramjeet S SandhuBrian J BallHoda PourhassanPaul KollerPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Azoles given concurrently or sequentially with midostaurin were found to be equally safe and effective in the treatment of newly diagnosed FLT3 AML. Additional confirmatory studies are needed due to our limited sample size.
Keyphrases
- acute myeloid leukemia
- newly diagnosed
- patients undergoing
- allogeneic hematopoietic stem cell transplantation
- liver failure
- tyrosine kinase
- drug induced
- respiratory failure
- intensive care unit
- case control
- radiation therapy
- combination therapy
- replacement therapy
- cell therapy
- hepatitis b virus
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome